JNCCN has released an invited article from the NCCN Best Practices Committee entitled “Safety at the Time of the COVID-19 Pandemic: How to Keep our Oncology Patients and Healthcare Workers Safe.”
With regards to diagnostics and molecular testing, the authors state, “Patients who require diagnostic biopsies… may undergo CT-guided biopsies if possible. Molecular testing and liquid biopsies may also be weighed for some circumstances.”
Click on the link to read the full article: https://lnkd.in/djrh3uw